Evidence map›Paper›PMID 40750594›Full record

ArticleNature communications2025

Lung structural cells are altered by infeluenza virus leading to rapid immune protection following re-challenge.

Julie C Worrell, Kerrie E Hargrave, George E Finney, Chris Hansell, John Cole, Jagtar Singh Nijjar, Fraser Morton, Marieke Pingen, Tom Purnell, Kathleen Mitchelson and 10 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Julie C WorrellSchool of Infection and Immunity, University of Glasgow, Glasgow, UK. Julie.worrell@ucd.ie.ORCID http://orcid.org/0000-0001-7754-1364
Kerrie E HargraveSchool of Infection and Immunity, University of Glasgow, Glasgow, UK.
George E FinneySchool of Infection and Immunity, University of Glasgow, Glasgow, UK.ORCID http://orcid.org/0000-0002-4230-4235
Chris HansellSchool of Infection and Immunity, University of Glasgow, Glasgow, UK.
John ColeSchool of Infection and Immunity, University of Glasgow, Glasgow, UK.
Jagtar Singh NijjarWeatherden Ltd, London, UK.
Fraser MortonSchool of Infection and Immunity, University of Glasgow, Glasgow, UK.ORCID http://orcid.org/0000-0001-5328-9467
Marieke PingenSchool of Infection and Immunity, University of Glasgow, Glasgow, UK.ORCID http://orcid.org/0000-0001-5689-9076
Tom PurnellSchool of Infection and Immunity, University of Glasgow, Glasgow, UK.
Kathleen MitchelsonSchool of Infection and Immunity, University of Glasgow, Glasgow, UK.
Euan BrennanSchool of Infection and Immunity, University of Glasgow, Glasgow, UK.ORCID http://orcid.org/0009-0004-5311-1676
Clíodhna M DalySchool of Infection and Immunity, University of Glasgow, Glasgow, UK.
Jay AllanMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Georgios IliaMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID http://orcid.org/0009-0003-4109-5966
Vanessa HerderMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID http://orcid.org/0000-0003-4814-1382
Claire Kennedy DietrichSchool of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Center, University of Glasgow, Glasgow, UK.
Yoana DonchevaSchool of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Center, University of Glasgow, Glasgow, UK.
Nigel B JamiesonSchool of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Center, University of Glasgow, Glasgow, UK.ORCID http://orcid.org/0000-0002-9552-4725
Massimo PalmariniMRC-University of Glasgow Centre for Virus Research, Glasgow, UK.ORCID http://orcid.org/0000-0001-7007-4070
Megan K L MacLeodSchool of Infection and Immunity, University of Glasgow, Glasgow, UK. Megan.MacLeod@glasgow.ac.uk.ORCID http://orcid.org/0000-0003-1843-8580

Funding

RCUK | Medical Research Council (MRC) MC_UU_00034/4Wellcome TrustWellcome Trust (Wellcome) 097821/Z/11/BWellcome Trust (Wellcome) 210703/Z/18/ZWellcome Trust (Wellcome) 226141/Z/22/Z
6 · The paper itself

Abstract

Lung structural cells form barriers against pathogens and trigger immune responses following infections. This leads to the recruitment of innate and adaptive immune cells some of which remain within the lung and contribute to enhanced pathogen control following subsequent infections. There is growing evidence that structural cells also display long-term changes following infection. Here we investigate long-term changes to mouse lung epithelial cells, fibroblasts, and endothelial cells following influenza virus infection finding that all three cell types maintain an imprint of the infection, particularly in genes linked to communication with T cells. MHCI and MHCII proteins continue to be expressed at higher levels in both differentiated epithelial cells and progenitor populations and several differentially expressed genes are downstream of the transcription factor, SpiB, a known orchestrator of antigen presentation. Lung epithelial cells from influenza-infected mice display functional changes, more rapidly controlling influenza virus than cells from naïve animals. This rapid anti-viral response and increased expression of molecules required to communicate with T cells demonstrates sustained and enhanced functions following infection. These data suggest lung structural cells display characteristics of immune memory which could affect outcomes that are protective in the context of infection or pathogenic in chronic inflammatory disorders.

Indexed as

Influenza A virusLungOrthomyxoviridae InfectionsAnimalsEndothelial CellsEpithelial CellsFemaleFibroblastsImmunologic MemoryMiceMice, Inbred C57BLT-Lymphocytes

Identifiers

PMID40750594
PMCPMC12317152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.